Medtronic, Stryker and Smith & Nephew are the market leaders of the minimally invasive surgical instruments market. The market is expected to hit USD 18.14 billion by 2021. Other companies which are also well established in the market are Ethicon, Aesculap, ConMed, Abbott Laboratories, Applied Biomedical Resources, Microline Surgical and Zimmer Biomet. The market is likely to grow at a CAGR of 10.2%. The key factors boosting the market growth include high demand among patients for minimally invasive surgical procedures over traditional surgeries and an increase in the number of procedures in the elderly population. The orthopedic segment captured the largest market share in 2015, owing to an increase in bone conditions and spine injuries. Private hospitals and surgical clinics accounted for the largest MIS instrument market share in 2015. North America dominated the market in 2015, but the Asia Pacific is considered to witness the highest growth rate.
Medtronic, Stryker and Smith & Nephew leading minimally invasive surgical instruments market
GHI Analysis1 min read
GHI Analysis
The leading source of MedTech market intelligence in Latin America. Verified data and competitor insights across the key markets in the region. At GHI, we turn hospital data into strategic actions. Our insights help healthcare companies expand by providing accurate, up-to-date information on hospital infrastructure in LATAM and Asia.
Related Posts
News
Global healthcare mobility solutions market may grow at 25-30% CAGR during 2015-2020
Global healthcare mobility solutions market may grow at 25-30% CAGR during 2015-2020
According to a report, the healthcare mobility solutions market is expected to grow at a…
GHI Analysisnovembro 16, 2015
Análise de GHI
Perspectiva para o mercado brasileiro de saúde em 2018
Perspectiva para o mercado brasileiro de saúde em 2018
Não é nenhuma surpresa afirmar que o Brasil é um dos mercados de saúde mais…
GHI Analysismarço 12, 2018
News
BD makes strategic review of respiratory business unit to pay off debts
BD makes strategic review of respiratory business unit to pay off debts
Becton Dickinson (BD) following the acquisition of CareFusion, is mulling selling its respiratory business segment,…
GHI Analysisabril 7, 2015